Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents.

Saez-Llorens, Xavier; Aguilera Vaca, Diana Catalina; Abarca, Katia; Maho, Emmanuelle; Graña, Maria Gabriela; Heijnen, Esther; Smolenov, Igor; Dull, Peter M

Saez-Llorens, Xavier; Aguilera Vaca, Diana Catalina; Abarca, Katia; Maho, Emmanuelle; Graña, Maria Gabriela; Heijnen, Esther; Smolenov, Igor; Dull, Peter M.

Affiliation

Saez-Llorens X; a Infectious Disease Department; Hospital del Niño ; Panama City , Panama.

Hum Vaccin Immunother ; 11(6): 1507-17, 2015.

Article in En | MEDLINE | ID: mdl-25969894

Subject(s)
Key words

AE, adverse event; CI, confidence interval; GMT, geometric mean titer; IMD, invasive meningococcal disease; NHBA, Neisserial Heparin Binding Antigen; NadA, Neisseria adhesin A; Neisseria meningitidis; OMV, outer membrane vesicle; PP, per-protocol set; SAE, serious adverse event; adolescents; conjugate vaccine; fHbp, factor H-binding protein; hSBA, serum bactericidal assay with human complement; immunogenicity; meningococcal disease; safety

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Investigational / Meningococcal Vaccines Type of study: Clinical_trials Limits: Adolescent / Female / Humans / Male Language: En Journal: Hum Vaccin Immunother Year: 2015 Document type: Article Affiliation country: Panamá Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google